Immix Biopharma Investor Presentation Deck
N-GENIUS Platform Overview
FIM
3 Key Elements
Purpose-Built Cell Therapy Evidence Capture
Engine + Relational Database
Relating ImmixBio internal data to external to accelerate
therapy design, manufacture, and preclinical
Proprietary EXPAND technology
Applied to multiple cell therapy indications, already utilized
to create NXC-201, to potentially increase efficacy and
tolerability
Atomized, Novel Binding Scaffold
Generation Engine
Allows us to make the correct binding for every molecule
N-GENIUS PLATFORM
Allows ImmixBio To...
Rapidly Pursue Additional Proven Target Indications
●●●
IMMİX
S BIOPHARMA
Optimize CAR-T constructs across CAR-T indications to reduce toxicity
without sacrificing efficacy to allow widespread adoption
Identify specific relevant binder optimizations in each CAR-T candidate to
increase or decrease binding affinity and avidly as appropriate
5View entire presentation